Vera Therapeutics, Inc.VERANASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-13.06%
↑ 77% vs avg
Percentile
P52
Within normal range
Streak
2 qtr
Consecutive declineStable
Average
-55.78%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -13.06% |
| Q3 2025 | -12.97% |
| Q2 2025 | -0.72% |
| Q1 2025 | -38.85% |
| Q4 2024 | -6.23% |
| Q3 2024 | -48.84% |
| Q2 2024 | 26.75% |
| Q1 2024 | -34.55% |
| Q4 2023 | -9.45% |
| Q3 2023 | -29.27% |
| Q2 2023 | 32.41% |
| Q1 2023 | -24.24% |
| Q4 2022 | -14.89% |
| Q3 2022 | 3.22% |
| Q2 2022 | -111.93% |
| Q1 2022 | -39.50% |
| Q4 2021 | -17.40% |
| Q3 2021 | 28.45% |
| Q2 2021 | -86.00% |
| Q1 2021 | 84.95% |
| Q4 2020 | -1019.00% |
| Q3 2020 | 8.52% |
| Q2 2020 | -16.05% |
| Q1 2020 | 0.00% |